Medical Device Import License India – Everything a Foreign Manufacturer Needs to Know

India’s medical device market is one of the most attractive in the world — a rapidly expanding healthcare sector, a government pushing domestic procurement, and over 1.4 billion patients. Yet every year, foreign manufacturers lose months — and sometimes entire market windows — because they underestimate what CDSCO’s import licensing process actually demands.

This guide cuts through the confusion. Whether you are a European OEM, a US manufacturer, or an Asian device company looking to enter India, here is exactly what you need to know about the medical device import license process under CDSCO — what it requires, where applications fail, and how to get it right the first time.

As of 2026, all notified medical devices, including Class A (Sterile & Measuring), Class B, Class C, and Class D, require appropriate licensing under CDSCO before import. There are no exceptions — even devices already approved by FDA, CE, or TGA must go through India’s own registration process.

This guide is designed for foreign manufacturers, OEMs, and global medical device companies looking to obtain CDSCO import license (MD-14 / MD-15) in India.

Who Needs a Medical Device Import License?

If you are a foreign manufacturer planning to sell medical devices in India, you cannot apply to CDSCO directly. Indian law requires that all import license applications be submitted through an Authorized Indian Agent (AIA) — a legally established Indian entity that takes regulatory responsibility for your device in India.

This means your very first step — before any documentation, before any application — is appointing the right Indian partner. Your agent’s competence directly determines how smoothly and how quickly your license is granted. A weak or inexperienced agent is one of the most common reasons applications get delayed or rejected.

Without an Authorized Indian Agent, import license applications cannot be filed under the Medical Device Rules, 2017. This requirement is non-negotiable for foreign manufacturers.

Legal Framework — What Governs Medical Device Imports in India

Medical device imports in India are regulated under two primary instruments:

•       Medical Device Rules, 2017 (MDR 2017) — the principal regulatory framework covering classification, licensing, labeling, and post-market requirements

•       Drugs and Cosmetics Act, 1940 — the parent legislation under which medical devices are regulated

The regulatory authority is the Central Drugs Standard Control Organization (CDSCO), operating under the Ministry of Health and Family Welfare. Applications are filed through the SUGAM online portal at CDSCO, and licenses are managed at the national level by the Central Licensing Authority (CLA).

The Two Forms You Must Know — MD-14 and MD-15

The import license process in India revolves around two specific forms:

Every field in the MD-14 form — model numbers, device names, shelf life, intended use — must match exactly across all supporting documents. Even minor inconsistencies between the form and the Device Master File are one of the top triggers for CDSCO queries and delays.

Device Classification — Why It Determines Everything

Before preparing a single document, you must correctly classify your device under India’s MDR 2017 risk classification system. Your device class determines the documentation depth, the approval pathway, the timeline, and the level of scrutiny your application will face.

Poor documentation adds 3 to 6 months to any timeline regardless of device class. CDSCO does not follow up on incomplete applications — the clock simply stops until you respond correctly.

Documents Required — Where Applications Pass or Fail

This is the most critical part of your application. The quality, consistency, and completeness of your documentation determines everything — approval speed, query volume, and ultimately, whether you get the license at all.

Step-by-Step Import License Process

1.    Appoint Authorized Indian Agent — Your first and most important decision. Your agent’s regulatory knowledge and CDSCO relationships directly affect your outcome.

2.    Device Classification — Confirm your device’s correct class under MDR 2017. Wrong classification means wrong documentation and guaranteed delay.

3.    Documentation Preparation — Prepare DMF, PMF, PoA, FSC, ISO 13485, test reports, and clinical evidence. All documents must be internally consistent — model numbers, intended use, and technical specifications must match exactly across every file.

4.    MD-14 Application Filing — Your agent submits the complete application through the CDSCO SUGAM portal with government fees paid. The application is reviewed for completeness before formal intake.

5.    Query Handling — CDSCO officers may raise queries on any aspect of the application. This is where most timelines extend. Slow, incomplete, or incorrect query responses can add months to approval. Your agent must respond quickly and precisely.

6.    MD-15 License Grant — Once CDSCO is satisfied, the MD-15 import license is issued. It is valid indefinitely subject to periodic retention fees (every 5 years). 

5 Mistakes That Guarantee Delays — And How to Avoid Them

1. Assuming CE or FDA Approval Is Enough

It is not. CDSCO conducts an independent review of every application. While reference country approvals (from USA, EU, UK, Japan, Australia, Canada) can speed up the process, they do not replace India-specific documentation. You still need a DMF, PMF, and FSC structured specifically for CDSCO requirements.

2. Weak or Improperly Apostilled Power of Attorney

The PoA must be notarized and apostilled in the country where the foreign manufacturer is located. Incorrect apostille, wrong signatory authority, or missing notarization leads to immediate rejection. This is the single most common document error ELT Corporate sees in incoming applications.

3. Copy-Paste Device Master File

CDSCO assessors are experienced. A DMF that is clearly adapted from another country’s submission — with inconsistent model numbers, irrelevant sections, or generic risk analysis — will attract multiple queries. Your DMF must be structured precisely for the Indian application and the specific models being registered.

4. Labeling and IFU Mismatch

If the intended use on your label does not match the intended use in the DMF, or if the IFU references features not covered by your test reports, CDSCO will issue a query. Every document must tell the same story about your device — consistently and precisely.

5. Underestimating Your Indian Agent

Your approval speed is heavily dependent on how competent your Authorized Indian Agent is. An agent who does not know CDSCO’s current preferences, query patterns, or portal requirements will cost you months. Choose your partner based on track record, not just price.

Government Fees for CDSCO Import License

CDSCO government fees for import license applications under MD-14 are:

• Class A – USD 1,000
• Class B – USD 3,000
• Class C & D – USD 5,000
• Additional product fees apply

All fees are paid through the CDSCO SUGAM portal.

Your Responsibilities After License Grant

Getting the MD-15 license is not the end of your compliance journey — it is the beginning of an ongoing obligation:

•       Post-Market Surveillance (PMS) — Continuous monitoring of device performance in the Indian market, including complaint handling and trend analysis

•       Adverse Event Reporting — Serious adverse events must be reported to CDSCO within defined timelines under MDR 2017

•       License Retention — Every 5 years, retention fees must be paid to keep the license active. Missing this deadline results in automatic lapse

•       Change Notifications — Any changes to device design, manufacturing site, labeling, or intended use must be notified to CDSCO. Selling a changed device under an old license is a compliance violation

•       CDSCO Inspections — CDSCO may conduct market surveillance or facility inspections. Your Indian agent must maintain updated records and be ready to respond

Many foreign manufacturers focus entirely on getting the license and then neglect post-market obligations. CDSCO has been actively strengthening its post-market surveillance framework in 2025-26. Ongoing compliance is not optional.

The Bottom Line

Getting a medical device import license in India is not inherently difficult — but doing it wrong is extremely costly. Foreign manufacturers who enter India with the right partner, properly structured documentation, and a clear understanding of CDSCO’s expectations consistently get their licenses approved on time and without avoidable queries.

Those who treat the Indian application as a simple adaptation of their existing FDA or CE documentation — or who choose their Indian agent purely on cost — consistently face delays, rejections, and lost market time.

India’s medical device market is growing too fast to afford those mistakes.